Work

Abstract PS1-12-17: Frequency and Prognostic Significance of ESR1 Mutations Post-CDK4/6 inhibitors in ER+/HER2− Metastatic Breast Cancer: Real-World Data from the GEICAM_RegistEM Study

Year: 2026
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7129482648
Cites:
Cited by: 1
Related to: